A cohort study demonstrated that patients with chronic kidney disease, diabetes, rheumatologic disease, cardiac disease, or lipid disorders and those who concomitantly used statins, aromatase inhibitors, or glucocorticoids had a significantly higher risk of tendon disorders (Chang et al., 2022). This evidence concerns the gene CYP19A1 and disease of the tendon.